Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Marco Filetti1, Manuela Petti2, Lorenzo Farina2

  • 1Uoc Fase 1, Fondazione Policlinico universitario Agostino Gemelli, Irccs, Roma - Dipartimento di Medicina sperimentale, Sapienza Università di Roma - Ph.D. Program in "Network oncology and precision medicine", Sapienza Università di Roma.

Recenti Progressi in Medicina
|August 2, 2023
PubMed
Summary
This summary is machine-generated.

Advancing medicine requires integrating artificial intelligence (AI) with diverse fields like genetics and molecular biology. This interdisciplinary approach is crucial for understanding complex diseases and improving patient outcomes.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of miR-335-5p in the redifferentiation of BRAF p.V600E thyroid cancers.

Molecular oncology·2026
Same author

Precision Medicine Through Network Language: Integrating Clinical Insight and Data Expertise.

Genes·2026
Same author

Artificial intelligence in oncology publishing: a systematic review and policy analysis of high-impact journals.

Frontiers in oncology·2026
Same author

ASGR2 and CLEC12A as Prognostically Relevant C-Type Lectin Hubs in Glioblastoma.

International journal of molecular sciences·2026
Same author

Temporal Patterns and Factors Associated with Early Termination in Phase 1 Clinical Trials for Solid Tumors.

Journal of the National Cancer Institute·2026
Same author

Network analysis predicts pembrolizumab response in advanced NSCLC with PD-L1 < 50.

Cancer cell international·2026
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
See all related articles

Area of Science:

  • Medicine
  • Genetics
  • Computational Biology
  • Molecular Biology